Pubblicazioni

Impact of prior antibiotic use in primary care on escherichia coli resistance to third generation cephalosporins. A case-control study

2021 - ANTIBIOTICS

Fulgenzio, C.; Massari, M.; Traversa, G.; Cas, R. D.; Ferrante, G.; Aschbacher, R.; Moser, V.; Pagani, E.; Vestri, A. R.; Massidda, O.; Kurotschka, P. K.

Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa

2020 - CLINICAL INFECTIOUS DISEASES

Vena, A.; Giacobbe, D. R.; Mussini, C.; Cattelan, A.; Bassetti, M.; Ceftabuse Study, Group; Oliva, A.

Genetic resistance determinants for cefixime and molecular analysis of gonococci isolated in Italy

2017 - MICROBIAL DRUG RESISTANCE

Carannante, A.; Vacca, P.; Ghisetti, V.; Latino, M. A.; Cusini, M.; Matteelli, A.; Vocale, C.; Prignano, G.; Leli, C.; Ober, P.; Antonetti, R.; Poletti, F.; Stefanelli, P.

Travelers can import colistin-resistant Enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene

2016 - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bernasconi, Oj; Kuenzli, E; Pires, J; Tinguely, R; Carattoli, A; Hatz, C; Perreten, V; Endimiani, A.